Skip to main content
SpringerLink
Log in

Proliferative Vitreoretinopathy

  • Chapter
Vitreoretinal Surgery

  • 940 Accesses

Abstract

Some detachments, especially when the detachment has been present for weeks or months, are complicated by proliferative vitreoretinopathy (PVR), a cellular proliferation producing “epiretinal membranes.” At presentation the rate of PVR in all patients with rhegmatogenous retinal detachment (RRD) varies depending on the ease of access to health care. Where access is prompt, 5% rates of PVR are expected; where access is delayed (when 2 months have passed before attending), PVR rates are much higher, e. g. 53% in South America [1] and 17. 5% in East Africa [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tseng W, Cortez RT, Ramirez G et al. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am. J. Ophthalmol. 2004;137:1105–15.

    Article  PubMed  Google Scholar 

  2. Yorston DB, Wood ML, Gilbert C. Retinal detachment in East Africa. Ophthalmology 2002;109:2279–83.

    Article  PubMed  Google Scholar 

  3. Bonnet M, Fleury J, Guenoun S et al. Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch. Clin. Exp. Ophthalmol. 1996;234:739–43.

    Article  PubMed  CAS  Google Scholar 

  4. Glaser BM, Cardin A, Biscoe B. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Ophthalmology 1987;94:327–32.

    PubMed  CAS  Google Scholar 

  5. Moisseiev J, Glaser BM. New and previously unidentified retinal breaks in eyes with recurrent retinal detachment with proliferative vitreoretinopathy. Arch. Ophthalmol. 1989;107:1152–4.

    PubMed  CAS  Google Scholar 

  6. Kon CH, Asaria RH, Occleston NL et al. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br. J. Ophthalmol. 2000;84:506–11.

    Article  PubMed  CAS  Google Scholar 

  7. Machemer R, Aaberg TM, Freeman HM et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am. J. Ophthalmol. 1991;112:159–65.

    PubMed  CAS  Google Scholar 

  8. Lewis H, Aaberg TM, Abrams GW et al. Subretinal membranes in proliferative vitreoretinopathy. Ophthalmology 1989;96:1403–14.

    PubMed  CAS  Google Scholar 

  9. Cowley M, Conway BP, Campochiaro PA et al. Clinical risk factors for proliferative vitreoretinopathy. Arch. Ophthalmol. 1989;107:1147–51.

    PubMed  CAS  Google Scholar 

  10. Glaser BM, Vidaurri-Leal J, Michels RG et al. Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology 1993;100:466–70.

    PubMed  CAS  Google Scholar 

  11. Duquesne N, Bonnet M, Adeleine P. Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch. Clin. Exp. Ophthalmol. 1996;234:677–82.

    Article  PubMed  CAS  Google Scholar 

  12. Han DP, Rychwalski PJ, Mieler WF et al. Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection. Am. J. Ophthalmol. 1994;118:24–32.

    PubMed  CAS  Google Scholar 

  13. Coll GE, Chang S, Sun J et al. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1995;102:630–8.

    PubMed  CAS  Google Scholar 

  14. Bourke RD, Cooling RJ. Vascular consequences of retinectomy. Arch. Ophthalmol. 1996;114:155–60.

    PubMed  CAS  Google Scholar 

  15. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch. Ophthalmol. 1992;110:780–92.

    Google Scholar 

  16. Barr CC, Lai MY, Lean JS et al. Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology 1993;100:1629–35.

    PubMed  CAS  Google Scholar 

  17. Wiedemann P, Hilgers RD, Bauer P et al. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am. J. Ophthalmol. 1998;126:550–9.

    Article  PubMed  CAS  Google Scholar 

  18. Charteris DG, Aylward GW, Wong D et al. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 2004;111:2240–5.

    Article  PubMed  Google Scholar 

  19. Stern WH, Lewis GP, Erickson PA et al. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am. J. Ophthalmol. 1983;96:33–42.

    PubMed  CAS  Google Scholar 

  20. Blumenkranz M, Hernandez E, Ophir A et al. 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 1984;91:122–30.

    PubMed  CAS  Google Scholar 

  21. Asaria RH, Kon CH, Bunce C et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, double-blind, controlled clinical trial. Ophthalmology 2001;108:1179–83.

    Article  PubMed  CAS  Google Scholar 

  22. Vidaurri-Leal J, de B S, Michels RG. Surgical treatment of giant retinal tears with inverted posterior retinal flaps. Am. J. Ophthalmol. 1984;98:463–6.

    Article  PubMed  CAS  Google Scholar 

  23. Stolba U, Binder S, Velikay M et al. Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications. Br. J. Ophthalmol. 1995;79:1106–10.

    Article  PubMed  CAS  Google Scholar 

  24. Fisher YL, Shakin JL, Slakter JS et al. Perfluoropropane gas, modified panretinal photocoagulation, and vitrectomy in the management of severe proliferative vitreoretinopathy. Arch. Ophthalmol. 1988;106:1255–60.

    PubMed  CAS  Google Scholar 

  25. Han DP, Lewis MT, Kuhn EM et al. Relaxing retinotomies and retinectomies. Surgical results and predictors of visual outcome. Arch. Ophthalmol. 1990;108:694–7.

    PubMed  CAS  Google Scholar 

  26. Cox MS, Trese MT, Murphy PL. Silicone oil for advanced proliferative vitreoretinopathy. Ophthalmology 1986;93:646–50.

    PubMed  CAS  Google Scholar 

  27. Iverson DA, Ward TG, Blumenkranz MS. Indications and results of relaxing retinotomy. Ophthalmology 1990;97:1298–304.

    PubMed  CAS  Google Scholar 

  28. Scott IU, Flynn HW, Lai M et al. First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am. J. Ophthalmol. 2000;130:745–50.

    Article  PubMed  CAS  Google Scholar 

  29. Lewis H, Aaberg TM. Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am. J. Ophthalmol. 1991;111:15–9.

    PubMed  CAS  Google Scholar 

  30. Mietz H, Heimann K. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease. Br. J. Ophthalmol. 1995;79:874–7.

    Article  PubMed  CAS  Google Scholar 

  31. Scott IU, Flynn HW, Jr., Murray TG et al. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am. J. Ophthalmol. 2003;136:454–63.

    Article  PubMed  Google Scholar 

  32. Diddie KR, Azen SP, Freeman HM et al. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Ophthalmology 1996;103:1092–9.

    PubMed  CAS  Google Scholar 

  33. Schwartz SD, Kreiger AE. Proliferative vitreoretinopathy: a natural history of the fellow eye. Ophthalmology 1998;105:785–8.

    Article  PubMed  CAS  Google Scholar 

  34. Lewis H, Verdaguer JI. Surgical treatment for chronic hypotony and anterior proliferative vitreoretinopathy. Am. J. Ophthalmol. 1996;122:228–35.

    PubMed  CAS  Google Scholar 

  35. O’Connell SR, Majji AB, Humayun MS et al. The surgical management of hypotony. Ophthalmology 2000;107:318–23.

    Article  PubMed  CAS  Google Scholar 

  36. Cox MS, Azen SP, Barr CC et al. Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study Report 8. Ophthalmology 1995;102:1884–91.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2008). Proliferative Vitreoretinopathy. In: Vitreoretinal Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-37582-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-37582-1_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-37581-4

  • Online ISBN: 978-3-540-37582-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation